KoreaMed Synapse

1

Intensity-Modulated Radiation Therapy for Uterine Cervical Cancer to Reduce Toxicity and Enhance Efficacy – an Option or a Must?: A Narrative Review

Sea-Won Lee, Aeran Kim, Sung Jong Lee, Sung Hwan Kim, Jong Hoon Lee

KMSID: 1516085746 Cancer Res Treat. 2024;56(1):1-17. Published online 2023 August 30 DOI: http://dx.doi.org/10.4143/crt.2023.562

18

Longitudinal Changes in Smoking Behaviors and Cancer-Related Mortality Risk in Middle-Aged Korean Women

Thi Xuan Mai Tran, Soyeoun Kim, Seonju Kim, Boyoung Park

KMSID: 1516085735 Cancer Res Treat. 2024;56(1):18-26. Published online 2023 August 2 DOI: http://dx.doi.org/10.4143/crt.2023.341

27

Trends and Clinical Characteristics of Next-Generation Sequencing–Based Genetic Panel Tests: An Analysis of Korean Nationwide Claims Data

Mi Jang, Hae Yong Pak, Ja Yoon Heo, Hyunsun Lim, Yoon-La Choi, Hyo Sup Shim, Eun Kyung Kim

KMSID: 1516085761 Cancer Res Treat. 2024;56(1):27-36. Published online 2023 September 7 DOI: http://dx.doi.org/10.4143/crt.2023.844

37

A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial

Kyoo Hyun Kim, Sun Min Lim, Hee Kyung Ahn, Yun-Gyoo Lee, Keun-Wook Lee, Myung-Ju Ahn, Bhumsuk Keam, Hye Ryun Kim, Hyun Woo Lee, Ho Jung An, Jin-Soo Kim

KMSID: 1516085740 Cancer Res Treat. 2024;56(1):37-47. Published online 2023 July 20 DOI: http://dx.doi.org/10.4143/crt.2023.433

48

Lazertinib versus Gefitinib as First-Line Treatment for EGFR-Mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset

Ki Hyeong Lee, Byoung Chul Cho, Myung-Ju Ahn, Yun-Gyoo Lee, Youngjoo Lee, Jong-Seok Lee, Joo-Hang Kim, Young Joo Min, Gyeong-Won Lee, Sung Sook Lee, Kyung-Hee Lee, Yoon Ho Ko, Byoung Yong Shim, Sang-We Kim, Sang Won Shin, Jin-Hyuk Choi, Dong-Wan Kim, Eun Kyung Cho, Keon Uk Park, Jin-Soo Kim, Sang Hoon Chun, Jangyoung Wang, SeokYoung Choi, Jin Hyoung Kang

KMSID: 1516085741 Cancer Res Treat. 2024;56(1):48-60. Published online 2023 June 27 DOI: http://dx.doi.org/10.4143/crt.2023.453

61

First-Line Alectinib vs. Brigatinib in Advanced Non–Small Cell Lung Cancer with ALK Rearrangement: Real-World Data

Youngkyung Jeon, Sehhoon Park, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn

KMSID: 1516085742 Cancer Res Treat. 2024;56(1):61-69. Published online 2023 July 14 DOI: http://dx.doi.org/10.4143/crt.2023.461

70

Tumor Microenvironment Modulation by Neoadjuvant Erlotinib Therapy and Its Clinical Impact on Operable EGFR-Mutant Non–Small Cell Lung Cancer

Beung-Chul Ahn, Charny Park, Moon Soo Kim, Jong Mog Lee, Jin Ho Choi, Hyae Young Kim, Geon Kook Lee, Namhee Yu, Youngjoo Lee, Ji-Youn Han

KMSID: 1516085743 Cancer Res Treat. 2024;56(1):70-80. Published online 2023 June 21 DOI: http://dx.doi.org/10.4143/crt.2023.482

81

Clinical Validation of the Unparalleled Sensitivity of the Novel Allele-Discriminating Priming System Technology–Based EGFR Mutation Assay in Patients with Operable Non–Small Cell Lung Cancer

Il-Hyun Park, Dae-Soon Son, Yoon-La Choi, Ji-Hyeon Choi, Ji-Eun Park, Yeong Jeong Jeon, Minseob Cho, Hong Kwan Kim, Yong Soo Choi, Young Mog Shim, Jung Hee Kang, Suzy Park, Jinseon Lee, Sung-Hyun Kim, Byung-Chul Lee, Jhingook Kim

KMSID: 1516085739 Cancer Res Treat. 2024;56(1):81-91. Published online 2023 June 20 DOI: http://dx.doi.org/10.4143/crt.2023.408

92

Strategies to Improve Smoking Cessation for Participants in Lung Cancer Screening Program: Analysis of Factors Associated with Smoking Cessation in Korean Lung Cancer Screening Project (K-LUCAS)

Yeol Kim, Jaeho Lee, Eunju Lee, Juntae Lim, Yonghyun Kim, Choon-Taek Lee, Seung Hun Jang, Yu-Jin Paek, Won-Chul Lee, Chan Wha Lee, Hyae Young Kim, Jin Mo Goo, Kui Son Choi, Boyoung Park, Duk Hyoung Lee, Hong Gwan Seo

KMSID: 1516085738 Cancer Res Treat. 2024;56(1):92-103. Published online 2023 August 7 DOI: http://dx.doi.org/10.4143/crt.2022.1598

104

Clinical Impact of Genomic and Pathway Alterations in Stage I EGFR-Mutant Lung Adenocarcinoma

Jae Seok Lee, Eun Kyung Kim, Kyung A Kim, Hyo Sup Shim

KMSID: 1516085757 Cancer Res Treat. 2024;56(1):104-114. Published online 2023 July 24 DOI: http://dx.doi.org/10.4143/crt.2023.728

115

Aggressive Local Ablative Radiotherapy Mitigates Progression Risk in Oligometastatic Lung Adenocarcinoma

Gowoon Yang, Kyung Hwan Kim, Chang Geol Lee, Min Hee Hong, Hye Ryun Kim, Yeona Cho, Hong In Yoon

KMSID: 1516085750 Cancer Res Treat. 2024;56(1):115-124. Published online 2023 August 29 DOI: http://dx.doi.org/10.4143/crt.2023.600

125

Impact of Social Support during Diagnosis and Treatment on Disease Progression in Young Patients with Breast Cancer: A Prospective Cohort Study

Danbee Kang, Seri Park, Hyo Jung Kim, Seok Won Kim, Jeong Eon Lee, Jonghan Yu, Se Kyung Lee, Ji-Yeon Kim, Seok Jin Nam, Juhee Cho, Yeon Hee Park

KMSID: 1516085755 Cancer Res Treat. 2024;56(1):125-133. Published online 2023 September 4 DOI: http://dx.doi.org/10.4143/crt.2023.673

134

Toremifene, an Alternative Adjuvant Endocrine Therapy, Is Better Than Tamoxifen in Breast Cancer Patients with CYP2D6*10 Mutant Genotypes

Xin Li, Zehao Li, Lin Li, Tong Liu, Cheng Qian, Yanlv Ren, Zhigao Li, Kejin Chen, Dongchen Ji, Ming Zhang, Jinsong Wang

KMSID: 1516085753 Cancer Res Treat. 2024;56(1):134-142. Published online 2023 August 14 DOI: http://dx.doi.org/10.4143/crt.2023.652

143

Short-term Impact of Hormone Replacement Therapy on Risk of Breast Cancer in BRCA Mutation Carriers: A Nationwide Study in South Korea

Hye Yeon Kim, Jisoo Park, Seok Joo Moon, Sohyeon Jeong, Jin Hwa Hong, Jae Kwan Lee, Geum Joon Cho, Hyun-Woong Cho

KMSID: 1516085754 Cancer Res Treat. 2024;56(1):143-148. Published online 2023 August 16 DOI: http://dx.doi.org/10.4143/crt.2023.653

149

Next-Generation Sequencing in Breast Cancer Patients: Real-World Data for Precision Medicine

Hyunwoo Lee, Yoon Ah Cho, Deok Geun Kim, Eun Yoon Cho

KMSID: 1516085759 Cancer Res Treat. 2024;56(1):149-161. Published online 2023 August 11 DOI: http://dx.doi.org/10.4143/crt.2023.800

162

Tumor Microenvironment Can Predict Chemotherapy Response of Patients with Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy

Dongjin Kim, Yeuni Yu, Ki Sun Jung, Yun Hak Kim, Jae-Joon Kim

KMSID: 1516085731 Cancer Res Treat. 2024;56(1):162-177. Published online 2023 July 24 DOI: http://dx.doi.org/10.4143/crt.2023.330

178

Changes in Invasive Breast Carcinomas after Neoadjuvant Chemotherapy Can Influence Adjuvant Therapeutic Decisions

Bárbara Jaime dos Santos, Débora Balabram, Virginia Mara Reis Gomes, Carolina Costa Café de Castro, Paulo Henrique Costa Diniz, Marcelo Araújo Buzelin, Cristiana Buzelin Nunes

KMSID: 1516085737 Cancer Res Treat. 2024;56(1):178-190. Published online 2023 August 1 DOI: http://dx.doi.org/10.4143/crt.2023.386

191

Functional Annotation and Gene Set Analysis of Gastric Cancer Risk Loci in a Korean Population

Hyojin Pyun, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Joohon Sung, Jeongseon Kim

KMSID: 1516085732 Cancer Res Treat. 2024;56(1):191-198. Published online 2023 June 20 DOI: http://dx.doi.org/10.4143/crt.2022.958

199

GASTric Cancer HER2 Re-Assessment Study 2 (GASTHER2): HER2 Re-assessment for Initially HER2-Negative Advanced Gastric Cancer Patients after Progression on First-Line Treatment

Jaewon Hyung, Hyung-Don Kim, Min-Hee Ryu, Young Soo Park, Meesun Moon, Yoon-Koo Kang

KMSID: 1516085744 Cancer Res Treat. 2024;56(1):199-207. Published online 2023 June 20 DOI: http://dx.doi.org/10.4143/crt.2023.490

208

First-in-Human Phase 1 Study of a B Cell– and Monocyte-Based Immunotherapeutic Vaccine against HER2-Positive Advanced Gastric Cancer

Minkyu Jung, Jii Bum Lee, Hyo Song Kim, Woo Sun Kwon, Hyun Ok Kim, Sinyoung Kim, Myunghwan Park, Wuhyun Kim, Ki-Young Choi, Taegwon Oh, Chang-Yuil Kang, Hyun Cheol Chung, Sun Young Rha

KMSID: 1516085733 Cancer Res Treat. 2024;56(1):208-218. Published online 2023 June 28 DOI: http://dx.doi.org/10.4143/crt.2022.1328

219

Genomic and Transcriptomic Characterization of Gastric Cancer with Bone Metastasis

Sujin Oh, Soo Kyung Nam, Keun-Wook Lee, Hye Seung Lee, Yujun Park, Yoonjin Kwak, Kyu Sang Lee, Ji-Won Kim, Jin Won Kim, Minsu Kang, Young Suk Park, Sang-Hoon Ahn, Yun-Suhk Suh, Do Joong Park, Hyung Ho Kim

KMSID: 1516085734 Cancer Res Treat. 2024;56(1):219-237. Published online 2023 August 11 DOI: http://dx.doi.org/10.4143/crt.2023.340

238

Association between Metabolically Healthy Status and Risk of Gastrointestinal Cancer

Haozhe Cui, Fei Tian, Yongliang Chen, Xiangming Ma

KMSID: 1516085745 Cancer Res Treat. 2024;56(1):238-246. Published online 2023 August 2 DOI: http://dx.doi.org/10.4143/crt.2023.539

247

Risk Stratification of Pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy

Hyun Kyung Yang, Mi-Suk Park, Kyunghwa Han, Geonsik Eom, Yong Eun Chung, Jin-Young Choi, Seungmin Bang, Chang Moo Kang, Jinsil Seong, Myeong-Jin Kim

KMSID: 1516085748 Cancer Res Treat. 2024;56(1):247-258. Published online 2023 August 22 DOI: http://dx.doi.org/10.4143/crt.2023.586

259

Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-Dependent Manner

Pei Cao, Weigang Zhang, Junyi Qiu, Zuxiong Tang, Xiaofeng Xue, Tingting Feng

KMSID: 1516085736 Cancer Res Treat. 2024;56(1):259-271. Published online 2023 August 16 DOI: http://dx.doi.org/10.4143/crt.2022.1600

272

Risk Factors for Distant Metastasis in Extrahepatic Bile Duct Cancer after Curative Resection (KROG 1814)

Younghee Park, Tae Hyun Kim, Kyubo Kim, Jeong Il Yu, Wonguen Jung, Jinsil Seong, Woo Chul Kim, Jin Hwa Choi, Ah Ram Chang, Bae Kwon Jeong, Byoung Hyuck Kim, Tae Gyu Kim, Jin Hee Kim, Hae Jin Park, Hyun Soo Shin, Jung Ho Im, Eui Kyu Chie

KMSID: 1516085751 Cancer Res Treat. 2024;56(1):272-279. Published online 2023 July 31 DOI: http://dx.doi.org/10.4143/crt.2023.616

280

Clear Cell Adenocarcinoma of Urethra: Clinical and Pathologic Implications and Characterization of Molecular Aberrations

Boram Song, Seok Hyun Lee, Jeong Hwan Park, Kyung Chul Moon

KMSID: 1516085747 Cancer Res Treat. 2024;56(1):280-293. Published online 2023 September 11 DOI: http://dx.doi.org/10.4143/crt.2023.577

294

Ten-Year Trends of Hematopoietic Stem Cell Transplantation in Korean Pediatric Cancer from the National Health Insurance Claims Data

Hyery Kim, Hwa Jung Kim, Youngjun Jo, Su Hyun Yoon, Young Kwon Koh, Sunghan Kang, Kyung-Nam Koh, Ho Joon Im

KMSID: 1516085749 Cancer Res Treat. 2024;56(1):294-304. Published online 2023 September 7 DOI: http://dx.doi.org/10.4143/crt.2023.598

305

Incidence and Features of Lymphoid Proliferation and Lymphomas after Solid Organ or Hematopoietic Stem Cell Transplantation in a National Database Cohort

Seung Min Hahn, Myeongjee Lee, JongHoon Hyun, Sungmin Lim, Ji-Man Kang, Jong Gyun Ahn, Dong Jin Joo, Inkyung Jung, Kyong Ihn

KMSID: 1516085752 Cancer Res Treat. 2024;56(1):305-313. Published online 2023 July 18 DOI: http://dx.doi.org/10.4143/crt.2023.647

314

Circulating Tumor DNA Reflects Histologic and Clinical Characteristics of Various Lymphoma Subtypes

Jin Ju Kim, Hye Min Kim, Hongkyung Kim, Soo-Jeong Kim, Seung-Tae Lee, Jong Rak Choi, Saeam Shin, Doh Yu Hwang

KMSID: 1516085756 Cancer Res Treat. 2024;56(1):314-323. Published online 2023 July 17 DOI: http://dx.doi.org/10.4143/crt.2023.667

324

Impact of T-Cell Engagers on COVID-19–Related Mortality in B-Cell Lymphoma Patients Receiving B-Cell Depleting Therapy

Chan Mi Lee, Pyoeng Gyun Choe, Chang Kyung Kang, Hyeon Jae Jo, Nam Joong Kim, Sung-Soo Yoon, Tae Min Kim, Wan Beom Park, Myoung-don Oh

KMSID: 1516085758 Cancer Res Treat. 2024;56(1):324-333. Published online 2023 July 6 DOI: http://dx.doi.org/10.4143/crt.2023.738

334

Clinical Features of Li-Fraumeni Syndrome in Korea

Ran Song, Sun-Young Kong, Wonyoung Choi, Eun-Gyeong Lee, Jaeyeon Woo, Jai Hong Han, Seeyoun Lee, Han-Sung Kang, So-Youn Jung

KMSID: 1516085760 Cancer Res Treat. 2024;56(1):334-341. Published online 2023 August 9 DOI: http://dx.doi.org/10.4143/crt.2023.794